• 0
MENU
Cart Details

Creart 0.25mg Injection

  • Home
  • Creart 0.25mg Injection

Product Informations: Creart 0.25mg Injection

In Female infertility Creart 0.25mg Injection prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy. It is given as an injection by a doctor or nurse and should not be self-administered. You should use the medicine as prescribed for it to be effective.

Your doctor or nurse will give you this medicine. Kindly do not self administer.
Creart 0.25mg Injection is an anti-gonadotropin-releasing hormone medicine. It is used in the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation. Creart 0.25mg Injection is injecting directly into the skin under the supervision of a doctor. Do not self administer the injection. Your doctor or nurse may help you to know the best way to inject the medicine at home. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. You should take this medicine for as long as it is prescribed for you. The most common side effects of this medicine include injection site reaction (redness, itching, and irritation), nausea and vomiting. To overcome irritation at the injection site, use a different part of belly every day to inject the medicine. Some side effects may mean you should inform your doctor immediately include dizziness, faint, abdominal pain, and vomiting. Before taking this medicine, tell your doctor if you have ever had liver or kidney disease or if you are breastfeeding to a baby. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works.
  • Ovarian hyperstimulation syndrome
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Irritation
  • Vomiting
  • Lower abdominal pain
Alcohol : CAUTION

Caution is advised when consuming alcohol with Creart 0.25mg Injection. Please consult your doctor.

Pregnancy : UNSAFE

Creart 0.25mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding : UNSAFE

Creart 0.25mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving : SAFE

Creart 0.25mg Injection does not usually affect your ability to drive.

Kidney : CAUTION

Creart 0.25mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Creart 0.25mg Injection may be needed. Please consult your doctor. However, the use of Creart 0.25mg Injection is not recommended in patients with severe kidney disease.

Liver : CAUTION

Creart 0.25mg Injection should be used with caution in patients with liver disease. Dose adjustment of Creart 0.25mg Injection may be needed. Please consult your doctor.

If you miss a dose of Creart 0.25mg Injection, please consult your doctor.

  • Q. Q. What is Creart 0.25mg Injection and for what it is used for??
    Ans: Creart 0.25mg Injection is an injectable preparation, which contains the active substance Ganirelix. It is used in women undergoing certain fertility treatments. It acts by blocking the release of luteinizing hormone (LH) thus preventing eggs from being released too early and gives the eggs time to grow properly. It is usually used in combination with other medicines.
  • Q. Q. How and in what dose can it be used??
    Ans: It is given as an injection, only at the hospital or clinic by the medical healthcare professional. The patient may be monitored regularly for the follicular development. The treatment duration depends on the ovarian response of the patient.
  • Q. Q. What may be the possible side effects associated with it??
    Ans: The most common side effect is local site reaction (redness of skin with or without swelling). You may also feel a headache or nausea. However, these effects are temporary, if these persist consult with your doctor. In addition, conditions like ovarian hyperstimulation syndrome (OHSS), and multiple births or birth defect, may also be associated with the use of this medicine.
  • Q. ?
    Ans:

FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra


Alternatives and Substitutes


Customer Reviews

No customer reviews yet.

References

FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More

European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More

ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More

Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More



Available options.

Same salt composition: Cetrorelix (0.25mg)

Test Buy medical disposable face mask
to protect your loved ones